Chemotherapy remains an essential element of personalized care for persons with lung cancers
Author:
Funder
National Cancer Institute
American Society of Clinical Oncology
National Institutes of Health
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/27/10/1829/7079887/mdw271.pdf
Reference112 articles.
1. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma;Karnofsky;Cancer,1948
2. Veterans administration surgical adjuvant lung cancer chemotherapy study—present status;Hughes;J Thorac Cardiovasc Surg,1962
3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004
4. EGF receptor gene mutations are common in lung cancers from ‘never smokers’ and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci USA,2004
5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hyaluronic acid based functionalization of nanodelivery systems: A promising strategy for CD44-receptors-mediated targeted therapy of lung cancer;Journal of Drug Delivery Science and Technology;2024-11
2. Reduction-Responsive Polyprodrug Nanoplatform Based on Curcumin for Tumor-Targeted Therapy;Current Drug Delivery;2024-07-24
3. Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis;European Journal of Pharmacology;2024-07
4. PET/CT Imaging in Lung Cancer;Journal of Nuclear Medicine Technology;2024-06
5. The potential role of circular RNAs -regulated PI3K signaling in non-small cell lung cancer: Molecular insights and clinical perspective;Pathology - Research and Practice;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3